NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026)

NewAmsterdam Pharma (NAMS) posted Other Non-Current Assets of $2.6 million for Q1 2026, up 32212.5% sequentially from $8000.0 in Q2 2024.

NewAmsterdam Pharma (NAMS) Other Non-Current Assets (2022 - 2026) Analysis & Trends

NewAmsterdam Pharma has reported Other Non-Current Assets for 4 years, with the latest figure at $2.6 million in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (changed N/A YoY) and the FY2023 annual result came in at $35000.0, down 77.56% from the prior year.
Other Non-Current Assets grew to $2.6 million in Q1 2026 per NAMS's latest filing, from $8000.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $2.6 million in Q1 2026 and troughed at $101.27 in Q2 2023.
A 4-year average of $465509.6 and a median of $25500.0 in 2023 frame the typical range for Other Non-Current Assets.
The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets tumbled 76.5% in 2023, then surged 7799.68% in 2024.
Over 4 years, Other Non-Current Assets stood at $148956.1 in 2022, then sank by 76.5% to $35000.0 in 2023, then sank by 77.14% to $8000.0 in 2024, then jumped by 32212.5% to $2.6 million in 2026.
According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.6 million, $8000.0, and $16000.0 for Q1 2026, Q2 2024, and Q1 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	124.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	42.45 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	109.58 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	18,237.65
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	62.96 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	65.13 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	104.44 Mn
10	NewAmsterdam Pharma	3.17 Bn	3.17 Bn	-	-

Download Data